San Diego, CA

John C. Hundley

Executive Vice President
T 858.369.3072 john.hundley@kidder.com
12230 El Camino Real, 4th Floor
San Diego, CA 92130
vCard Bio

John has 17 years of extensive experience in the commercial real estate industry. Joining Kidder Mathews in 2016, he is responsible for developing and delivering strategic advisory and brokerage services on behalf of early-stage, middle market and growth oriented companies in the life science, healthcare, and tech verticals.

Recognized in the life science ecosystem for his passion, thought leadership, and his ability to deliver excellent outcomes, John’s advisory experience includes office, R&D laboratory, and mission-critical production facilities for some of the world’s most innovative start-ups, public biotechs, pharma and healthcare companies.

While the majority of John’s work is focused on advising occupiers, he is well recognized and often called upon by institutional investor/developers for insight and advice.

Prior to joining the firm, John helped lead CBRE San Diego’s Life Science Practice, and was one of the youngest participants of their Global Life Science Advisory Committee. John is a co-leader of the Kidder Mathews life science services group for the overall market positioning, strategic initiatives and key business development efforts in San Diego.


Tenant representation, strategic advisory and portfolio planning for the life science, healthcare, and technology industries.

Affiliations & Awards

Groundhog Award, Life Science Expertise

RISE Award, Leadership

Kidder Mathews “Big Hitters” Top Producers award, 2017, Top 5 Southwest & Southern California

Broker of the Year Award, 2019, Kidder Mathews Southwest & Southern California Property Management Award

Kidder Mathews Top Producers award, 2019, #1 Southwest & Southern California Region


MASTERS OF SCIENCE, Christian Studies, Regent College

MASTERS OF SCIENCE, Real Estate, University of San Diego

BACHELOR OF ARTS, Psychology, Point Loma Nazarene University, San Diego, CA

Select Client List

  • Anabios
  • AnaptysBio (NASDAQ: ANAB)
  • Bentall Kennedy
  • Cardinal Health
  • Celyad (NASDAQ: CYAD)
  • Cordant Health Solutions
  • Curology
  • DTx Pharma
  • Edico Genome
  • Emergent BioSolutions (NYSE: EBSI)
  • Explora BioLabs
  • Johnson & Johnson - DePuy Synthes (NASDAQ: JNJ)
  • Nucleus Biologics
  • Pacira Biosciences (NASDAQ: PCRX)
  • PaxVax
  • Renew Bioindustries
  • Roswell Biosciences
  • Scripps Health
  • United Therapeutics (NASDAQ: UTHR)